Advertisement

Pediatric Nephrology

, Volume 21, Issue 7, pp 917–930 | Cite as

Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement

  • John D. MahanEmail author
  • Bradley A. Warady
  • Consensus Committee
Conference Report

Abstract

Growth failure is a clinically important issue in children with chronic kidney disease (CKD) and is associated with significant morbidity and mortality. Many factors contribute to impaired growth in these children, including abnormalities in the growth hormone (GH)–insulin-like growth factor-I (IGF-I) axis, malnutrition, acidosis, and renal bone disease. The management of growth failure in children with CKD is complicated by the presence of other disease-related complications requiring medical intervention. Despite evidence of GH efficacy and safety in this population, some practitioners and families have been reluctant to institute GH therapy, citing an unwillingness to comply with daily injections, reimbursement difficulties, or impending renal transplantation. Suboptimal attention to growth failure management may be further compounded by a lack of clinical guidelines for the appropriate assessment and treatment of growth failure in these children. This review of growth failure in children with CKD concludes with an algorithm developed by members of the consensus committee, outlining their recommendations for appropriate steps to improve growth and overall health outcomes in children with CKD.

Keywords

Growth hormone Chronic renal insufficiency Chronic kidney disease Dialysis Renal transplant Growth failure 

References

  1. 1.
    Furth SL, Stablein D, Fine RN, Powe NR, Fivush BA (2002) Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 109:909–913PubMedCrossRefGoogle Scholar
  2. 2.
    Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR (2002) Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 17:450–455PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Hokken-Koelega AC, Saenger P, Cappa M, Greggio N (2001) Unresolved problems concerning optimal therapy of puberty in children with chronic renal diseases. J Pediatr Endocrinol Metab 14 [Suppl 2]:945–952PubMedPubMedCentralGoogle Scholar
  4. 4.
    Kari JA, Gonzalez C, Ledermann SE, Shaw V, Rees L (2000) Outcome and growth of infants with severe chronic renal failure. Kidney Int 57:1681–1687PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Kuizon BD, Salusky IB (1999) Growth retardation in children with chronic renal failure. J Bone Miner Res 14:1680–1690CrossRefGoogle Scholar
  6. 6.
    Postlethwaite RJ, Eminson DM, Reynolds JM, Wood AJ, Hollis S (1998) Growth in renal failure: a longitudinal study of emotional and behavioural changes during trials of growth hormone treatment. Arch Dis Child 78:222–229PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Scharer K (1990) Growth and development of children with chronic renal failure. Study Group on Pubertal Development in Chronic Renal Failure. Acta Paediatr Scand Suppl 366:90–92PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Tonshoff B, Mehls O (1995) Growth retardation in children with chronic renal insufficiency: current aspects of pathophysiology and treatment. J Nephrol 8:133–142Google Scholar
  9. 9.
    National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease. National Kidney Foundation. Accessed 13 Sept 2004Google Scholar
  10. 10.
    North American Pediatric Renal Transplant Cooperative Study (2005) Annual Report. Renal transplantation, dialysis, chronic renal insufficiency. Available at: https://doi.org/spitfire.emmes.com/study/ped/resources/annlrept2005.pdf. Accessed 2 Sept 2005
  11. 11.
    Tonshoff B, Fine RN (1996) Recombinant human growth hormone for children with renal failure. Adv Ren Replace Ther 3:37–47CrossRefGoogle Scholar
  12. 12.
    Stabler B, Siegel PT, Tancer ME (1993) Psychiatric symptoms in young adults treated for growth hormone deficiency in childhood. In: Stabler B, Underwood L (eds) Growth, stature, and adaptation. Behavioral, social and cognitive aspects of growth delay. University of North Carolina, Chapel Hill, NC, pp 99–106Google Scholar
  13. 13.
    Stabler B, Siegel PT, Clopper RR, Stoppani CE, Compton PG, Underwood LE (1998) Behavior change after growth hormone treatment of children with short stature. J Pediatr 133:366–373PubMedCrossRefGoogle Scholar
  14. 14.
    Stabler B, Clopper RR, Siegel PT, Stoppani C, Compton PG, Underwood LE (1994) Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study. J Dev Behav Pediatr 15:1–6PubMedCrossRefGoogle Scholar
  15. 15.
    Hokken-Koelega AC, van Zaal MA, van Bergen W, de Ridder MA, Stijnen T, Wolff ED, de Jong RC, Donckerwolcke RA, de Muinck Keizer-Schrama SM, Drop SL (1994) Final height and its predictive factors after renal transplantation in childhood. Pediatr Res 36:323–328PubMedCrossRefGoogle Scholar
  16. 16.
    Fine RN, Stablein D (2005) Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry. Pediatr Nephrol 20:404–408CrossRefGoogle Scholar
  17. 17.
    Nissel R, Brazda I, Feneberg R, Wigger M, Greiner C, Querfeld U, Haffner D (2004) Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney Int 66:792–800PubMedCrossRefGoogle Scholar
  18. 18.
    Voss LD, Sandberg DE (2004) The psychological burden of short stature: evidence against. Eur J Endocrinol 151 [Suppl 1]:S29–S33PubMedCrossRefGoogle Scholar
  19. 19.
    Busschbach JJ, Rikken B, Grobbee DE, De Charro FT, Wit JM (1998) Quality of life in short adults. Horm Res 49:32–38PubMedCrossRefGoogle Scholar
  20. 20.
    Broyer M, Le BC, Charbit M, Guest G, Tete MJ, Gangnadoux MF, Niaudet P (2004) Long-term social outcome of children after kidney transplantation. Transplantation 77:1033–1037PubMedCrossRefGoogle Scholar
  21. 21.
    Rosenkranz J, Reichwald-Klugger E, Oh J, Turzer M, Mehls O, Schaefer F (2005) Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease. Pediatr Nephrol 20:1288–1294PubMedCrossRefGoogle Scholar
  22. 22.
    Roelfsema V, Clark RG (2001) The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure. J Am Soc Nephrol 12:1297–1306PubMedPubMedCentralGoogle Scholar
  23. 23.
    Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F (2005) Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Pediatr Nephrol 20:313–318CrossRefGoogle Scholar
  24. 24.
    Tonshoff B, Kiepe D, Ciarmatori S (2005) Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 20:279–289PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Schaefer F, Veldhuis JD, Robertson WR, Dunger D, Scharer K (1994) Immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure. Kidney Int 45:1465–1476PubMedCrossRefGoogle Scholar
  26. 26.
    Wuhl E, Schaefer F (1999) Puberty in chronic renal failure. Adv Ren Replace Ther 6:335–343PubMedCrossRefGoogle Scholar
  27. 27.
    Kaskel F (2003) Chronic renal disease: a growing problem. Kidney Int 64:1141–1151CrossRefGoogle Scholar
  28. 28.
    North American Pediatric Renal Transplant Cooperative Study (2003) Annual report. Renal transplantation, dialysis, chronic renal insufficiency. https://doi.org/spitfire.emmes.com/study/ped/resources/annlrept2003.pdf. Accessed 15 Jan 2004
  29. 29.
    Betts PR, Magrath G (1974) Growth pattern and dietary intake of children with chronic renal insufficiency. Br Med J 2:189–193PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Karlberg J, Schaefer F, Hennicke M, Wingen AM, Rigden S, Mehls O (1996) Early age-dependent growth impairment in chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. Pediatr Nephrol 10:283–287PubMedCrossRefGoogle Scholar
  31. 31.
    Uauy RD, Hogg RJ, Brewer ED, Reisch JS, Cunningham C, Holliday MA (1994) Dietary protein and growth in infants with chronic renal insufficiency: a report from the Southwest Pediatric Nephrology Study Group and the University of California, San Francisco. Pediatr Nephrol 8:45–50PubMedCrossRefGoogle Scholar
  32. 32.
    Parekh RS, Flynn JT, Smoyer WE, Milne JL, Kershaw DB, Bunchman TE, Sedman AB (2001) Improved growth in young children with severe chronic renal insufficiency who use specified nutritional therapy. J Am Soc Nephrol 12:2418–2426PubMedPubMedCentralGoogle Scholar
  33. 33.
    Wingen AM, Mehls O (2002) Nutrition in children with preterminal chronic renal failure. Myth or important therapeutic aid? Pediatr Nephrol 17:111–120PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Caldas A, Broyer M, Dechaux M, Kleinknecht C (1992) Primary distal tubular acidosis in childhood: clinical study and long-term follow-up of 28 patients. J Pediatr 121:233–241PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Maniar S, Kleinknecht C, Zhou X, Motel V, Yvert JP, Dechaux M (1996) Growth hormone action is blunted by acidosis in experimental uremia or acid load. Clin Nephrol 46:72–76PubMedPubMedCentralGoogle Scholar
  36. 36.
    Bushinsky DA, Frick KK (2000) The effects of acid on bone. Curr Opin Nephrol Hypertens 9:369–379PubMedCrossRefGoogle Scholar
  37. 37.
    Lim VS, Kopple JD (2000) Protein metabolism in patients with chronic renal failure: role of uremia and dialysis. Kidney Int 58:1–10PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Boirie Y, Broyer M, Gagnadoux MF, Niaudet P, Bresson JL (2000) Alterations of protein metabolism by metabolic acidosis in children with chronic renal failure. Kidney Int 58:236–241PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53:205–211PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Hochberg Z (2002) Mechanisms of steroid impairment of growth. Horm Res 58 [Suppl 1]:33–38PubMedGoogle Scholar
  41. 41.
    National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2000) Clinical practice guidelines for nutrition in chronic renal failure. National Kidney Foundation. Accessed 15 Jan 2004Google Scholar
  42. 42.
    Kaufman DB (1998) Growth hormone and renal osteodystrophy: a case report. Pediatr Nephrol 12:157–159CrossRefGoogle Scholar
  43. 43.
    Fine RN, Kohaut EC, Brown D, Perlman AJ (1994) Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatr 124:374–382CrossRefGoogle Scholar
  44. 44.
    Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J (2000) Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol 14:701–706PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Kari JA, Rees L (2005) Growth hormone for children with chronic renal failure and on dialysis. Pediatr Nephrol 20:618–621CrossRefGoogle Scholar
  46. 46.
    Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 343:923–930CrossRefGoogle Scholar
  47. 47.
    Hokken-Koelega AC, Stijnen T, de Ridder MA, de Muinck Keizer-Schrama SM, Wolff ED, de Jong MC, Donckerwolcke RA, Groothoff JW, Blum WF, Drop SL (1994) Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 343:1313–1317PubMedCrossRefGoogle Scholar
  48. 48.
    Berard E, Crosnier H, Six-Beneton A, Chevallier T, Cochat P, Broyer M (1998) Recombinant human growth hormone treatment of children on hemodialysis. French Society of Pediatric Nephrology. Pediatr Nephrol 12:304–310PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Jabs K, Van DC, Harmon WE (1993) Growth hormone treatment of growth failure among children with renal transplants. Kidney Int Suppl 43:S71–S75PubMedGoogle Scholar
  50. 50.
    Guest G, Berard E, Crosnier H, Chevallier T, Rappaport R, Broyer M (1998) Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology. Pediatr Nephrol 12:437–446CrossRefGoogle Scholar
  51. 51.
    Fine RN, Stablein D, Cohen AH, Tejani A, Kohaut E (2002) Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 62:688–696CrossRefGoogle Scholar
  52. 52.
    Vimalachandra D, Craig JC, Cowell CT, Knight JF (2001) Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials. J Pediatr 139:560–567PubMedCrossRefGoogle Scholar
  53. 53.
    Maxwell H, Rees L (1998) Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology. Arch Dis Child 79:481–487PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Powell DR, Liu F, Baker BK, Hintz RL, Lee PD, Durham SK, Brewer ED, Frane JW, Watkins SL, Hogg RJ (1997) Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney Int 51:1970–1979PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Wuhl E, Haffner D, Nissel R, Schaefer F, Mehls O (1996) Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol 10:294–298PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Fine RN, Brown DF, Kuntze J, Wooster P, Kohaut EE (1996) Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency. The Genentech Cooperative Study Group. J Pediatr 129:883–891PubMedCrossRefGoogle Scholar
  57. 57.
    Fine RN, Yadin O, Moulton L, Nelson PA, Boechat MI, Lippe BM (1994) Five years experience with recombinant human growth hormone treatment of children with chronic renal failure. J Pediatr Endocrinol 7:1–12PubMedCrossRefGoogle Scholar
  58. 58.
    Wollmann HA, Schonau E, Blum WF, Meyer F, Kruse K, Ranke MB (1995) Dose-dependent responses in insulin-like growth factors, insulin-like growth factor-binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency. Horm Res 43:249–256PubMedCrossRefGoogle Scholar
  59. 59.
    Van Dyck M, Gyssels A, Proesmans W, Nijs J, Eeckels R (2001) Growth hormone treatment enhances bone mineralisation in children with chronic renal failure. Eur J Pediatr 160:359–363PubMedCrossRefGoogle Scholar
  60. 60.
    Hull KL, Harvey S (2003) Growth hormone therapy and quality of life: possibilities, pitfalls and mechanisms. J Endocrinol 179:311–333PubMedCrossRefGoogle Scholar
  61. 61.
    Lilien MR, Schroder CH, Levtchenko EN, Koomans HA (2004) Growth hormone therapy influences endothelial function in children with renal failure. Pediatr Nephrol 19:785–789PubMedCrossRefGoogle Scholar
  62. 62.
    Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R (2001) Cardiac mass and function, carotid artery intima–media thickness, and lipoprotein levels in growth hormone-deficient adolescents. J Clin Endocrinol Metab 86:1061–1065PubMedCrossRefGoogle Scholar
  63. 63.
    Szczepaniska KJ, Tolwinska J, Urban M, Gardziejczyk M, Glowinska B (2004) Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency. J Pediatr Endocrinol Metab 17:1405–1413Google Scholar
  64. 64.
    Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, de Horatio LT, Lombardi G, Colao A (2004) Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy. Clin Endocrinol (Oxf) 60:630–636CrossRefGoogle Scholar
  65. 65.
    Fine RN, Ho M, Tejani A, Blethen S (2003) Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 142:539–545PubMedCrossRefGoogle Scholar
  66. 66.
    Mentser M, Breen TJ, Sullivan EK, Fine RN (1997) Growth-hormone treatment of renal transplant recipients: the National Cooperative Growth Study experience—a report of the National Cooperative Growth Study and the North American Pediatric Renal Transplant Cooperative Study. J Pediatr 131:S20–S24PubMedCrossRefGoogle Scholar
  67. 67.
    Haffner D, Nissel R, Wuhl E, Schaefer F, Bettendorf M, Tonshoff B, Mehls O (1998) Metabolic effects of long-term growth hormone treatment in prepubertal children with chronic renal failure and after kidney transplantation. Pediatr Res 43:209–215CrossRefGoogle Scholar
  68. 68.
    Saenger P, Attie KM, DiMartino-Nardi J, Fine RN (1996) Carbohydrate metabolism in children receiving growth hormone for 5 years. Chronic renal insufficiency compared with growth hormone deficiency, Turner syndrome, and idiopathic short stature. Genentech Collaborative Group. Pediatr Nephrol 10:261–263PubMedCrossRefGoogle Scholar
  69. 69.
    Hertel NT, Holmberg C, Ronnholm KA, Jacobsen BB, Olgaard K, Meeuwisse GW, Rix M, Pedersen FB (2002) Recombinant human growth hormone treatment, using two dose regimens in children with chronic renal failure—a report on linear growth and adverse effects. J Pediatr Endocrinol Metab 15:577–588PubMedCrossRefGoogle Scholar
  70. 70.
    Boechat MI, Winters WD, Hogg RJ, Fine RN, Watkins SL (2001) Avascular necrosis of the femoral head in children with chronic renal disease. Radiology 218:411–413PubMedCrossRefGoogle Scholar
  71. 71.
    Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Wit JM, Wolff ED, de Jong MC, Donckerwolcke RA, Abbad NC, Bot A, Blum WF (1991) Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338:585–590PubMedCrossRefGoogle Scholar
  72. 72.
    Hokken-Koelega AC, Stijnen T, de Jong MC, Donckerwolcke RA, de Muinck Keizer-Schrama SM, Blum WF, Drop SL (1994) Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency. J Clin Endocrinol Metab 79:1185–1190PubMedGoogle Scholar
  73. 73.
    Hokken-Koelega AC, Stijnen T, de Jong RC, Donckerwolcke RA, Groothoff JW, Wolff ED, Blum WF, de Muinck Keizer-Schrama SM, Drop SL (1996) A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Kidney Int Suppl 53:S128–S134Google Scholar
  74. 74.
    Genentech (2005) Nutropin AQ [somatropin (rDNA origin) injection]. Prescribing informationGoogle Scholar
  75. 75.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J (2000) High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech Inc Cooperative Study Group. J Clin Endocrinol Metab 85:3653–3660PubMedGoogle Scholar
  76. 76.
    Mericq MV, Eggers M, Avila A, Cutler GB Jr, Cassorla F (2000) Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. J Clin Endocrinol Metab 85:569–573PubMedGoogle Scholar
  77. 77.
    Saggese G, Ranke MB, Saenger P, Rosenfeld RG, Tanaka T, Chaussain JL, Savage MO (1998) Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27–28 March 1998. Horm Res 50:320–340PubMedCrossRefGoogle Scholar
  78. 78.
    Bryant J, Cave C, Mihaylova B, Chase D, McIntyre L, Gerard K, Milne R (2002) Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technol Assess 6:1–168PubMedCrossRefGoogle Scholar
  79. 79.
    Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, Nippoldt TB, Rodbard HW, Seibel JA, Vance ML, Zimmermann D, Palumbo PJ, Bergman DA, Garber JR, Hamilton CR Jr, Petak SM, Rettinger HI, Service FJ, Shankar TP, Stoffer SS, Tourletot JB, American Association of Clinical Endocrinologists Growth Hormone Task Force (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children—2003 update. Endocr Pract 9:64–76PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    National Kidney Foundation (NKF) (2003) National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(Suppl 3):S1–S201Google Scholar

Copyright information

© IPNA 2006

Authors and Affiliations

  • John D. Mahan
    • 1
    Email author
  • Bradley A. Warady
    • 2
  • Consensus Committee
  1. 1.Department of Pediatrics, Division of Pediatric NephrologyThe Ohio State University COMPHColumbusUSA
  2. 2.The Children’s Mercy Hospitals and ClinicsSection of Pediatric NephrologyKansas CityUSA

Personalised recommendations